You are here: Industry Insights > Vaccine

News List

USP Offers Support for Developers of COVID-19 Antiviral Drugs and Vaccines americanpharmaceuticalreview
March 23, 2020
The U.S. Pharmacopeia (USP) is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic.
High-density microarray patch could provide alternative to syringe vaccine delivery europeanpharmaceuticalreview
March 23, 2020
A clinical trial has shown that delivery of vaccines via a new high-density microarray patch (HD-MAP) induces a better immune response than needles or syringes.
CEPI finds eighth Covid-19 partner in Institut Pasteur pharmaceutical-technology
March 23, 2020
The Norwegian Coalition for Epidemic Preparedness Innovations (CEPI) has made a $4.9m investment in a Covid-19 vaccine consortium led by the Paris-based Institut Pasteur.
iBio Developing Proprietary COVID-19 Vaccine Candidates contractpharma
March 23, 2020
iBio, Inc., a biologics contract manufacturing organization (CMO) and biotechnology company, is progressing towards developing vaccine candidates for preventing infection ...
China injects volunteers with test vaccine, showing strong research capability globaltimes
March 23, 2020
Chinese volunteers in a clinical trial for the first COVID-19 vaccine developed by the country's military scientists received injections on Friday ...
EC offers €80m to CureVac for COVID-19 vaccine development europeanpharmaceuticalreview
March 20, 2020
The European Commision (EC) has announced €80 million of support to aid in the R&D and production of a COVID-19 coronavirus vaccine.
Novel thermally-stable COVID-19 vaccine capsule developed europeanpharmaceuticalreview
March 20, 2020
Developers have announced that they are ready to manufacture and formulate an innovative novel coronavirus vaccine capsule.
Emergent BioSolutions and Vaxart partner on oral coronavirus vaccine pharmaceutical-technology
March 20, 2020
Emergent BioSolutions has agreed to provide molecule-to-market contract development and manufacturing (CDMO) services for Vaxart’s oral vaccine candidate against Covid-19 coronavirus infection.
CanSinoBIO, Synairgen get regulatory approval for Covid-19 trials pharmaceutical-technology
March 20, 2020
China-based CanSino Biologics has received regulatory approval to conduct Phase I clinical trial of recombinant novel coronavirus vaccine (adenovirus type 5 vector) candidate.
Covid-19: Entos and Takis to work on separate vaccines pharmaceutical-technology
March 20, 2020
Entos Pharmaceuticals is set to develop a DNA vaccine for Covid-19 coronavirus infection using its Fusogenix drug delivery platform.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page